Journal article
Do sulphonylureas still have a place in clinical practice?
Abstract
Sulphonylureas have been commercially available since the 1950s, but their use continues to be associated with controversy. Although adverse cardiovascular outcomes in some observational studies have raised concerns about sulphonylureas, findings from relatively recent, robust, and high-quality systematic reviews have indicated no increased risk of all-cause mortality associated with sulphonylureas compared with other active treatments. Results …
Authors
Khunti K; Chatterjee S; Gerstein HC; Zoungas S; Davies MJ
Journal
The Lancet Diabetes & Endocrinology, Vol. 6, No. 10, pp. 821–832
Publisher
Elsevier
Publication Date
10 2018
DOI
10.1016/s2213-8587(18)30025-1
ISSN
2213-8587